"newer" "traditional" "ultraviruses," (2):S6. (2005) (2008). (2011). (2012). (2013) (2015). (2017). (Abedon (Ackermann (Br (Brussow (Catalao (Chan (Cisek (Comeau (Curtright (Dethlefsen (FL): (Fischetti (Fortier (Gilmer (Hagens (Hall (Kim (Kovacs (Lu (Matsuda (Matsuzaki (Meader (Meander (Merabishvili (Moradpour (NY): (PAS) (PAS): (Pastagia (Pirnay (QA/QC) (Rice (Russel (Schuch (Summer (Summers (Vaks (Viertel (Waters (and - -sensitive 1 1(2):66-85. 11(1):69-86. 137:639-46. 140 146:843-857. 14:524-31. 16:549-54. 16S 18:1140-7. 1917 192:23-32. 1940, 1951), 1951). 1951. 197:1079-81. 1997). 1997. 1:247-57. 2000. 2001). 2001. 2002). 2002. 2003) 2003). 2003. 2004), 2004). 2004. 2005). 2005. 2005.Classification 2007) 2007). 2007. 2008), 2008). 2008. 2009). 2009. 2010). 2010. 2011 2011) 2011). 2011. 2012), 2012). 2012. 2013) 2013). 2013. 2014), 2014). 2014. 2015). 2015. 2017). 2017. 22:25-30. 24 28:934-937. 296:67-71. 2:836. 2:e799. 2nd 3 3.6% 30%, 300:357-62. 32:2173-2179. 35 36 37:218-23. 38 418:884-9. 48:3817-22. 4:554-71. 5,136 5-23. 55:738-44. 57:2743-50. 60 68:560-602. 69:2326-36. 6:e280. 7(12):e2709. 70% 70:S2-S6. 72:666-7. 73:7358-66. 74:277-283. 78:5646-5652. 8(6):769-83. 8-16 96% 9:58. A A, A. AA, AJ, AM, AR, Abedon Acinetobacter Ackermann Advantages After Agents Ahsen Also, Although Anaerobe. Another Antimicrob Antimicrob. Appl Appl. Arch. As At B, BG, BK, Bacillus Bacteria Bacterial Bacteriophage Bacteriophage. Bacteriophages Bacteriophages, Bacteriophages: Bangladesh Baton Because Behind Benhar Beta-lactam Bioanal Bioconj Biol. Biology Biomed. Biotechnol. Blasdel Blasi Both Br Bretaudeau British Broad Brussow Buckling C, C. CFU's CRC CW, Calendar Canchaya Carding Catalao Cha Chahales Chan Chem. Chemother. Chronic Cisek Cited Clostridium Comeau Concerns Conclusion Conventional Curr Curtright Cycles D'Herelle D, DB, DR, DW, Dabrowska De Dethlefsen Dis. Discovery Diversity Dual-surface-modified During E, E. EH, EM, EM. ESKAPE ESKAPE, ESKAPE. EW, Early Ecosystem Effects Emergent Endolysins Enterobacter Enterococcus Environ Environ. Era Escherichia Euler Evaluation F, FEMS Federal Felix Filamentous Firmicutes Fischetti For Fortier Freeman Frequency Friman From Future G, Gasson Gene. Genetically Germany. Gil Gilmer Gram-negative Gram-positive Gregorczyk Gvasalia H, HP. HW. Habel Hagens Hall Hardt Hilbert Hooker Horz However, Huse I, I. If Immune In In: Infect Int Interest Introduction It J J). J, J. JD, JE, JM, JP, Jang Journal. K, KP, Kaman Keywords: Kim Klebsiella Koeris Kovacs Kuhl Kutter L, LB. LC, Lett Lett. Linderoth Listeria Literature Liverpool, Loc-Carrillo Lu Lung Lysis-deficient M, MJ, ML, MRSA, MS. MS2 Matsuda Matsuzaki Mayer Meader Meander Med Medical Merabishvili Microb. Microbiol. Modified Moineau Mol. Moniz-Pereira Moradpour Morphological Most NA, Nanobiotechnology. Narbad Nature. Neill Nelson New No Not Novel Nutr. O104:H4 ONE. Once One One. Opin Other Oxford P, P. PEGylation PEGylation, PELP20 PLoS Pastagia Phage Phage-antibiotic Phages Pharm Pharm. Pirnay PlySs2, Pre-Antibiotic Press. Pret-a-porte Previous Proteobacteria Pseudomonas Purpose Quality R, Rahbarizadeh Rashel Relevance Res. Researchers Rev. Rice Ritter Romanini Rouge Russel S, S. SJ, SN, SR, ST, ST. Sali Schmitz Schuch Selection Sepehrizadeh Sogin Some Specific Staphylococcus Steverding Streptococcus Sulakvelidze Summers Surgery. T, T-helper T4 TA, TK, TM, Targeted Temperate Tetart The Therapy There These They This Thorax. Though To Treatment Trojet U, U. UK Uchiyama Unfortunately University Usage Using VA. VISA, VP, Vaks Variation Verbeken Viertel Virol. Virulence Virulent Viruses Von Vos WC. WD. Waters With Would Wyzewski York Z, Z. a abandoned ability able acceptance acceptance, accomplished acronym activated activator active activity adapted adaptive addition address adequately administer administration administration, adults advantage advantages advent adverse advise aeruginosa aeruginosa, aeruginosa. affected after again against agar agent agent, agent. agents agents, agents. agents: ago ago, ahead aid al. al., all allowed almost alone already also altered altering alternative although amount an and and/or animals another anthracis. anti-infective antibacterial antibacterials antibiotic antibiotic-resistant antibiotic-resistant, antibiotics antibiotics, antibiotics. antimicrobial any appeared applications applications. applied approaches appropriate appropriately approval approved approved, are argue arisen arose arsenal artificially as assembly: assess assurance at attached attaching aureus aureus, aureus. avenues bacteria bacteria's bacteria, bacteria. bacterial bactericidal bacteriolytic bacteriophage bacteriophage, bacteriophages bacteriophages, bacteriophages. bacterium bacterium’s balance based, baumanni, be beads because become becomes been before begins being believe believed benefits between binary bind bind, binds biocontrol bioengineered biofilm biofilms blood body body, both brief broad broadening bronchiectasis, but by can candidate capable, capacity capsid-based carry case catabolite categories cause caused causes causing cautioned cell cell, cells cells. century certain challenges challenging chance change changes characteristics characterization characterized chemical chimeric choosing chose chosen chronic circulation circumnavigate circumvent cleared clearing clinical cocktail cocktails cocktails); cocktails, coded coincided coined coli coli. collection colon colony-forming combat combination combining comes coming commensal common commonly community complete completed completely component composed con concern. concerns conclude concluded conditions, conducted constant constructed contact containing contamination contribute contributors control conventional conversion. could counted country create created creation credited critical cubic, current currently cycle cycle, cycled cystic d'Herelle days days, deadly death decolonization decrease decreased decreases deep degradation, delivery demand demonstrate demonstrated demonstrates derived describe described descriptions desired detected, detects determine detriment detrimental develop developed, developing development developments diarrhea-causing did differ different difficile difficile. difficult diminished, directions, directly disadvantages disadvantages, discover discovered discovered, discovery discovery, discovery. disease diseases diseases. distributed diverse diversity do doing done dose drawbacks drug drug-carrying dual due d’Herelle early easier easily edition. editor. editors. effect effective effective, effective. effectivity effects effects, effects. effects: efficacy either electron eliminate emphasis encountered encourage encouraged end endolysin endolysin, endolysins endolysins, endolysins: endotoxin endotoxins engineered engineering ensure enter enteroaggregative entirely environment environment. environmental environments enzyme enzymes enzymes, epidermidis, equipment especially established established. et evaluation even events eventually every evolution evolve evolved example, examples excited exhaustive experiencing experiment experiment, experiment. experimental experiments, exploration exploring export extensive facing factor factors faecium failure fall fallen faster features, few fibrosis fibrosis, fifteen fighting filamentous filamentous, first fitness five flora focus followed food for foreign forms found four from funding further future future, gastrointestinal gene genera general generation genes genes, genetic genetically genome, genomic given given. glycol, grew groups growth growth, growth. gut had happens harbouring harm; harmful has have he health. healthcare healthy help high higher highlight highlights highly highly-regulated hijacks history history. homogenized, hope hospital hospitals, host hours hours, how human humans hundred idea ideal identified if immediately immune immunocompromised immunological impacted implement implemented implications implicit improve improved improves in in, include including incorporating increase increased increases increasing indicate indicated indicates indicating indication individuals individuals? inducer-independent industrial ineffective infect infect, infected infecting infection infection, infections infections, infections. infectious inflammatory information inhalation injected injecting injection innate instead integrate intend intended interactions interest interfere interval, into intracellular intranasal intravenous introduced introducing introduction investigate investing investment is isolated issues it its jurisdictions key kill killed killed, kills known laboratory lag larvae. layer least less lethal levels licensing light likelihood likely limits living localization, located log long long-term longer looking lower lung lungs lyse lysed lyses lyses. lysin lysing lysis lysis-deficient lysogenic lysogenization lysogeny lytic made mainly majority makes making manner manufacturing many materials, may mean meaning means, meant mechanism mechanisms mechanisms, mediator medical medications membranes met methicillin-resistant method method, methodologies methods mice mice, mice’s microbes microbes, microbes. microbiota microbiota, microflora microscope might minimal mixed model model. modeled modified molecules, monomethoxypolyethylene more morphological most moth mouse much multidrug-resistant multiple, mupirocin murine must mutant mutate nanomedicines. narrow nasopharynx, natural natural, naturally naturally-occurring ne necessarily need needs net new new, next niche nine no non-cystic non-immunogenic non-lytic nonreplicating normal nosocomial not noted noticed novel now number oThe obscured observation observed obstructive obtain occurred occurring occurs of often older on once one only opportunistic opportunity optimal option or oral order other otherwise outbreak outer outside over overview paper paradigm: particles, particular passing pathogen pathogens pathogens, pathogens. pathogens: patient patients patients’ pending penetrate peptidoglycan period peritonitis pertinent pervasive phage phage's phage, phage-derived phage-mediated phage-products phage. phages phages, phages. phages? phages” phage’s pharmacology. phase phenomenon photosensitizers, pili, pilot place placebos plants plated pleomorphic pleural pneumoniae, population. populations posed posit positive posits possibility possible possibly potential potentially pp. practice: practices presence present prevent prevention prevents previously primary problem problematic problems procedures; process process, processes product production production, production. products products, products. products; progeny proliferate, promising promote promoter properties; property prophylactic proposed prospect protect protected protects protein proteins provide pulmonary pure purified purified. pursuit pyogenes pyogenes, quality quinolone rRNA racing range rate rates reached, reaches reactions readily rearrangements recent recently receptors recommended recovered recovery reduce reduced reduces reduction referred regularly release release, relevance remained remaining remedy removal removed replicate replicates, replication report reported required requirements research research, research: researchers resilience resistance resistance, resistant resources respectively. respiratory respond response response. responses responsible result result, resulted results resurgence revealed reversibly review revised revival rise risen rising risk role route routinely safe, safety same samples sandwiched sanguinis, scaffold scientific scientists search second seemed selecting selective sequencing. sequential serve setting seven share shelf-lives, shifted shock should show shown shows side significance, significant significantly similar simple simply simultaneous since site six six-day skeptical, skin smaller so so, solutions solutions, solutions: some soon sources species species, specific specifications, specificity specificity, spectrum spent spores. stage standards statistically stay step still stimulate stock stool storage strain strain-specific, strains strains, strains. structure structures studies study study, study. subjects substance, substances substantial success successful successfully such suffer suffering suggest suggested suis, superiority sur-mesure? surface surged. surgeries surveillance survival susceptibility susceptible suspensions, sustainable symmetry symptoms synergistic synergy synthesis system system, system. systemic systems systems, systems: tailed-phages take taken. takes target target. targeted targets targets, targets. temperate tendency term test tested testing tests, than that the their them theme. then therapeutic therapeutics therapy therapy, therapy. therapy: there therefore these they thick third this those though threaten three threshold, through time time, timing titers to tool toxic toxin toxins toxins, traditional traditionally traits transduce transducing transfer travel treat treated treatment treatment: treatments treatments, trials twenty-four two type types: typically ultimately unable uncover undergo units unknown. untreatable up usage usage. usage: use used useless uses using utilize utilized varied variety various vectors, vegetative versus very viable viral virion virions virtually virulence virulent viruses viruses, visualized vital vitro vivo wait wall wall, walls warnings was wax way way. ways well well-suited were what when where whereas which while who whose why wider widespread will with within within, without working world would year years yet ϴCD27 “modified “phages,”